National Cooperative Growth Study in CKD

The purpose of this study is to learn whether growth hormone being administered to children with Chronic Kidney Disease is effective and if it has any side effects.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Growth Hormone Deficiency Bone Diseases Bone Diseases, Developmental Bone Diseases, Endocrine Brain Diseases Central Nervous System Diseases Chronic Disease Disease Attributes Dwarfism Dwarfism, Pituitary Endocrine System Diseases Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Hypopituitarism Hypothalamic Diseases Kidney Diseases Kidney Failure, Chronic Male Urogenital Diseases Musculoskeletal Diseases Nervous System Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Pituitary Diseases Renal Insufficiency Renal Insufficiency, Chronic Urogenital Diseases Urologic Diseases

Age range

1 day–18 year

Sex eligibility

All sexes

Study type

Observational

Primary location

UC Davis Medical Center

Sacramento, California, 95817, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Must be a patient of the UC Davis Medical Center pediatric clinic with Chronic Kidney Disease

Exclusion criteria

Greater than 18 years old
Not a patient at the UC Davis Medical Center pediatric clinic

Treatment and study plan

Primary outcomes

The primary outcome measures of the NCGS are ongoing safety and efficacy of Genentech GH preparations in pediatric growth disorders for which GH is initiated.

Time frame: per the study, the pt will be on GH treatement until the physician instructs them to stop

Sponsors and collaborators

Lead sponsor

University of California, Davis

Other

Collaborators

Genentech, Inc.

Registry information

Official study title

National Cooperative Growth Study of Nutropin AQ, Nutropin, Protropin, and Nutropin Depot in Children With Growth Failure Due to Chronic Renal Insufficiency (CRI) or End-Stage Renal Disease (ESRD)

Acronym: NCGS

Important dates

Study start: 2005
Primary completion: 2010
Study completion: 2010
First posted: Feb 15, 2008
Registry last updated: May 30, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed